Rephonic
Artwork for Biotech 2050 Podcast

Biotech 2050 Podcast

Biotech 2050
Biotechnology
Oncology
Cell Therapy
Ophthalmology
Gene Therapy
Aging Biology
Biotech
Venture Capital
KRAS G12V
Microglia
Precision Medicine
Cancer Metastasis
AI In Drug Development
Gene Editing
Drug Discovery
Cystic Fibrosis
Clinical Trials
Precision Oncology
Breast Cancer
Sloan Kettering

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

PublishesTwice monthlyEpisodes245Founded6 years ago
Number of ListenersCategory
Science

Listen to this Podcast

Artwork for Biotech 2050 Podcast

Latest Episodes

Synopsis: Jim Tananbaum, Founder & CEO of Foresite Capital, joins Rahul Chaturvedi to dissect the patterns driving biotech innovation, the role of macroeconomic cycles in venture performance, and how disciplined science fuels enduring investment succ... more

Synopsis: Host Rahul Chaturvedi sits down with Geoffrey Duyk, Chief Executive Officer of Grove Biopharma, for a wide-ranging conversation on navigating today’s biotech macro headwinds and building companies that can translate breakthrough science int... more

Synopsis: Few biotechs can pull off what Syndax Pharmaceuticals has achieved — two first-in-class oncology drug launches, built entirely through strategic in-licensing and disciplined execution. In this episode, host Alok Tayi sits down with Michael ... more

Synopsis: When biotech meets bold partnerships, new models of innovation emerge. In this episode of the Biotech 2050 Podcast, host Rahul Chaturvedi welcomes Paul Biondi, Managing Partner at Flagship Pioneering, and Uli Stilz, Vice President, R&D Exte... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Recent Guests

Jim Tananbaum
Founder and CEO of Foresite Capital
Foresite Capital
Episode: Foresite Capital’s Jim Tananbaum on Biotech Cycles, AI Breakthroughs & Long-Term Value
Geoffrey Duyk
Co-founder and CEO of Grove Biopharma
Grove Biopharma
Episode: Geoffrey Duyk, Grove Biopharma CEO, on Polymer Breakthroughs, Intractable Targets & Biotech's Future
Michael Metzger
CEO of Syndax Pharmaceuticals
Syndax Pharmaceuticals
Episode: Syndax CEO Michael Metzger on Bold Leadership, Dual Drug Launches & Redefining Cancer Care
Paul Biondi
Managing Partner at Flagship Pioneering
Flagship Pioneering
Episode: Co-creating Breakthroughs in R&D: Paul Biondi (Flagship) & Uli Stilz (Novo Nordisk)
Uli Stilz
Corporate VP of R&D External Innovation Partners at Novo Nordisk
Novo Nordisk
Episode: Co-creating Breakthroughs in R&D: Paul Biondi (Flagship) & Uli Stilz (Novo Nordisk)
Kevin Caldwell
CEO and co-founder of Ossium Health, focused on improving healthcare through biotechnological innovation.
Ossium Health
Episode: Kevin Caldwell, Ossium Health CEO, on Cell Therapy, Vertical Integration & Immune Healthspan
AmirAli Talasaz
Co-founder and co-CEO of Guardant Health
Guardant Health
Episode: Rewriting Cancer: AmirAli Talasaz, Co-CEO of Guardant Health, on Liquid Biopsy, Data & Biotech Grit
Amy Burroughs
CEO of Terns Pharmaceuticals
Terns Pharmaceuticals
Episode: Terns CEO Amy Burroughs on CML Innovation, Obesity Drug Breakthroughs & Leading Biotech Forward
Jeremy Bender
CEO at Day One Biopharmaceuticals
Day One Biopharmaceuticals
Episode: Jeremy Bender, Day One CEO, on Transforming Pediatric Cancer Care & Leading Biotech with Purpose

Hosts

Rahul Chaturvedi
Co-founder and host, specializing in discussions about the biotech industry and its future innovations.
Alok Tayi
CEO and co-founder, with expertise in leading biotech initiatives and innovations.

Reviews

4.8 out of 5 stars from 173 ratings
  • Wonderful Diversity of Leadership

    Bravo! From patient focus, to capital formation, to commercial expertise… these conversations are engaging and meaningful to the bio ecosystem.

    Apple Podcasts
    5
    Sae36
    United States2 years ago
  • Sounds like a sales pitch

    I was hoping to hear about some interesting technology, but the first 20 minutes sounded like a sales pitch and slagging competitors. I ran out of patience so couldn’t finish it.

    Apple Podcasts
    1
    John-Hernry2
    Australia4 years ago
  • Intense knowledge to absorb

    Very well done podcast with tons of information that sounds like a freaking french to me but, after while you listening the podcast, you'll realize that you are smarter than before... damn... keep up the good work...

    Apple Podcasts
    5
    bimmerx
    Canada5 years ago
  • Finally!

    Love where this is going, been looking for a podcast to keep me up on the latest and greatest happenings in biotech.

    Apple Podcasts
    5
    TR-iumph
    United States6 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners appreciate the diverse leadership insights and meaningful discussions on the changing biotech landscape.
There are mixed opinions, with some appreciating the depth of information while others feel certain episodes stray into sales pitches rather than focusing on technology.
The podcast is commended for its ability to simplify complex topics, ultimately making listeners feel more informed about biotech innovations.
Listeners express a desire for more engaging content that directly addresses intriguing technological advancements.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#134
Argentina/Science
Apple Podcasts
#213
Spain/Science
Apple Podcasts
#221
Japan/Science

Talking Points

Recent interactions between the hosts and their guests.

Foresite Capital’s Jim Tananbaum on Biotech Cycles, AI Breakthroughs & Long-Term Value
Q: As we look into the future, what excites you about new therapeutics and healthcare?
Jim expresses enthusiasm for a shift towards preventative healthcare driven by individualized data and AI, enabling earlier detection and treatment of diseases.
Foresite Capital’s Jim Tananbaum on Biotech Cycles, AI Breakthroughs & Long-Term Value
Q: Given the current environment, what have you seen in terms of the shift in venture investing from 2021, 2022 to now?
Jim describes how public markets have compressed valuations, leading to more concentrated capital raises, and emphasizes the importance of securing funding during challenging times.
Foresite Capital’s Jim Tananbaum on Biotech Cycles, AI Breakthroughs & Long-Term Value
Q: For those that are listening that perhaps aren't as well-versed in terms of the interplay between interest rates and opportunities in venture, could you explain that interplay a bit more, given where we are?
Jim explains that with long-dated investments, a peak cash flow model shows how significantly interest rates can impact valuations, particularly in biotechnology when forecasting several years out.
Geoffrey Duyk, Grove Biopharma CEO, on Polymer Breakthroughs, Intractable Targets & Biotech's Future
Q: Given all your varied experience across the sector now, what's one piece of advice you wish you could provide your younger self knowing what you now know?
Listen more, say less.
Geoffrey Duyk, Grove Biopharma CEO, on Polymer Breakthroughs, Intractable Targets & Biotech's Future
Q: What do you think are the major drivers in terms of R&D inefficiency in the US right now across the life sciences sector?
Key drivers include misalignment of capital timelines, unpredictability of preclinical models, and challenges in clinical development.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Biotech 2050 Podcast

What is Biotech 2050 Podcast about and what kind of topics does it cover?

This podcast offers in-depth discussions on the many forces reshaping the biotech landscape, emphasizing innovative breakthroughs, industry trends, and explorations of future healthcare scenarios. A range of guests, including CEOs and experts from leading biotech firms, share insights on cutting-edge developments in areas such as gene therapy, cancer diagnostics, and drug discovery. Noteworthy themes include the significance of patient-centric approaches, the role of AI in drug development, and the urgent need for impactful drug therapies to meet unmet medical needs in various fields. The insights shared are aimed at informing professionals and stakeholders about the evolving challenges and opportunities in biotechnology.

Where can I find podcast stats for Biotech 2050 Podcast?

Rephonic provides a wide range of podcast stats for Biotech 2050 Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Biotech 2050 Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Biotech 2050 Podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Biotech 2050 Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Biotech 2050 Podcast?

Rephonic provides comprehensive predictive audience data for Biotech 2050 Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Biotech 2050 Podcast have?

To see how many followers or subscribers Biotech 2050 Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Biotech 2050 Podcast?

These podcasts share a similar audience with Biotech 2050 Podcast:

1. BioCentury This Week
2. Biotech Hangout
3. The Long Run with Luke Timmerman
4. The Readout Loud
5. Business Of Biotech

How many episodes of Biotech 2050 Podcast are there?

Biotech 2050 Podcast launched 6 years ago and published 245 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Biotech 2050 Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Biotech 2050 Podcast?

Rephonic pulls ratings and reviews for Biotech 2050 Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Biotech 2050 Podcast?

Rephonic provides full transcripts for episodes of Biotech 2050 Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Biotech 2050 Podcast?

Recent guests on Biotech 2050 Podcast include:

1. Jim Tananbaum
2. Geoffrey Duyk
3. Michael Metzger
4. Paul Biondi
5. Uli Stilz
6. Kevin Caldwell
7. AmirAli Talasaz
8. Amy Burroughs

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days